Copy For Citation
Demirturk N., AYGEN B., Celik I., Mistik R., AKHAN S., Barut S., ...More
TURKISH JOURNAL OF GASTROENTEROLOGY, vol.32, no.2, pp.155-163, 2021 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
32
Issue:
2
-
Publication Date:
2021
-
Doi Number:
10.5152/tjg.2020.19569
-
Journal Name:
TURKISH JOURNAL OF GASTROENTEROLOGY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
-
Page Numbers:
pp.155-163
-
Keywords:
Chronic hepatitis C, sofosbuvir, ledipasvir, sustained virological response, genotype, real-world data, SOFOSBUVIR PLUS RIBAVIRIN, GENOTYPE 1 INFECTION, TREATMENT-NAIVE, ANTIVIRAL THERAPY, HCV INFECTION, OPEN-LABEL, LEDIPASVIR, SAFETY, LEDIPASVIR/SOFOSBUVIR
-
Dokuz Eylül University Affiliated:
Yes
Abstract
Background: In this study, we aimed to investigate the efficacy and safety of sofosbuvir-based therapies in the treatment of chronic hepatitis C in real-world clinical practice.